I am with those who wrote about the inefficiencies of this board. We keep seeing a certain person boast and post about BO and bidding wars. Those never get taken down but any challenge to those gets deleted immediately.
Recently, the is the response I got from a moderator "Posts about the company are "on topic"everything else is "off topic" "
17mln debt is absolutely pittance. Please open any biotech company and look their liabilities. So I have no idea why this point point is being brought up again and again. Unless of course writers of 17mln has ulterior motive as to plant seeds of doubt on new investors who don't know much in investing or trading. Basic comparison will show you that 17mln is not a problem at all.
"Few Years" in Europe. It has not been FEW YEARS. Sehnance was purchased September 2015 and they really started marketing it in 2016 first quarter. Since then they sold 3 pieces in Europe.
FDA clearance will give TRXC more confidence to ramp up sales. FL hospital used Senhance, loved it and bought it. No one buys 1.5mln dollar equipment if it wouldn't benefit them.
More sales are coming! 100mln in cash so 17mln debt got nothing on us. TRXC can pay it off any moment.
hopefully sustainable. Just depends on what burn is per month. the hype is def there. I believe its slower in Europe bc socialistic medicine controlled by the government.
News 
Market Data 
Discover 
